• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

BNORights Issue - Letter to Nominees18/03/13
BNOBionomics CEO Named BioSpectrum Asia Person of the Year 201318/03/13
BNORights Issue - Letter to Eligible Shareholders05/03/13
BNOUnderwritten Rights Issue Offer BookletPRICE SENSITIVE04/03/13
BNOCleansing Notice Under Section 708AA of the Corporations Act04/03/13
BNOAppendix 3B04/03/13
BNOUnderwritten Rights Issue to Raise $16.4 MillionPRICE SENSITIVE04/03/13
BNOTrading HaltPRICE SENSITIVE28/02/13
BNOAppendix 3B15/02/13
BNOHalf Yearly Report and AccountsPRICE SENSITIVE14/02/13
BNOBNO Provides BNC101 Update at US Cancer Stem Cell ConferencePRICE SENSITIVE11/02/13
BNOBNC375 Alzheimer's Disease Data Presented at ConferencePRICE SENSITIVE04/02/13
BNOBionomics NOW February 2013 Newsletter01/02/13
BNOAppendix 3B31/01/13
BNOAppendix 4C - quarterlyPRICE SENSITIVE31/01/13
BNOBionomics R&D Tax Incentive for FY2012PRICE SENSITIVE15/01/13
BNOCEO Update and US Investor PresentationPRICE SENSITIVE09/01/13
BNOFinal Director's Interest Notice03/01/13
BNOBNC210 US TRIALPRICE SENSITIVE21/12/12
BNOAppendix 3B21/12/12
BNOBionomics New Alzheimer's Drug CandidatePRICE SENSITIVE14/12/12
BNOAppendix 3B12/12/12
BNOChange of Director's Interest Notice12/12/12
BNOChange of Director's Interest Notice12/12/12
BNOChange of Director's Interest Notice12/12/12
BNOAnnual General Meeting 2012 Results14/11/12
BNOOutgoing Chairman's Address14/11/12
BNOCEO & Managing Director AGM Presentation 2012PRICE SENSITIVE14/11/12
BNOCEO Broadcast - IND Application for Anti-Anxiety Drug09/11/12
BNOIND Submission to FDA for BNC210 Anti-Anxiety Drug CandidatePRICE SENSITIVE08/11/12
BNOAppendix 4C - quarterlyPRICE SENSITIVE31/10/12
BNOChange in substantial holding29/10/12
BNOBionomics ASX Small to Mid Caps Investor Presentation17/10/12
BNOALPHA 7 PROGRAM TO BE SHOWCASED AT NEUROSCIENCE 2012PRICE SENSITIVE16/10/12
BNONotice of Annual General Meeting/Proxy Form12/10/12
BNOBionomics Annual Report 201212/10/12
BNORetirement of Chairman11/10/12
BNOChange of Director's Interest Notice05/10/12
BNOAppendix 3B03/10/12
BNOChange of Director's Interest Notice02/10/12
BNOChange of Director's Interest Notice26/09/12
BNOAppendix 3B26/09/12
BNOCleansing Notice Under Section 708A of the Corporations Act26/09/12
BNOInitial Director's Interest Notice20/09/12
BNOInitial Director's Interest Notice20/09/12
BNOChange in substantial holding18/09/12
BNOBionomics Appoints Graeme Kaufman Non-Executive Director18/09/12
BNOBNO Acquires US-Based Cancer Stem Cell Company Presentation17/09/12
BNOBionomics Acquires US-Based Cancer Stem Cell CompanyPRICE SENSITIVE17/09/12
BNOBionomics Key Additions to Executive Team12/09/12
BNOFDA Approval for IronwoodPRICE SENSITIVE31/08/12
BNOAppendix 3B21/08/12
BNOBionomics August 2012 Investor Presentation17/08/12
BNOChange of Director's Interest Notice15/08/12
BNOFull Year Statutory Accounts15/08/12
BNOBionomics' 2011/2012 Preliminary Final ResultsPRICE SENSITIVE15/08/12
BNOBionomics Secures Key US Patent for VDA BNC105PRICE SENSITIVE15/08/12
BNOAppendix 3B02/08/12
BNOAppendix 4C - quarterlyPRICE SENSITIVE30/07/12
BNOBionomics NOW July 2012 Newsletter06/07/12
BNOOpen Briefing - CEO on Kv1.3 Program and OutlookPRICE SENSITIVE27/06/12
BNOUS Patent Granted for Kv1.3 ProgramPRICE SENSITIVE26/06/12
BNOChange of Director's Interest Notice19/06/12
BNOAppendix 3B15/06/12
BNOBionomics to Expand KV1.3 ProgramPRICE SENSITIVE15/06/12
BNOCEO Broadcast - BNC105 Trial Data13/06/12
BNOBNC105 Trial Data Presented at ASCOPRICE SENSITIVE01/06/12
BNOBionomics Launches BNC105 Ovarian Cancer TrialPRICE SENSITIVE24/05/12
BNOLife Sciences Conference Investor Presentation23/05/12
BNOChange of Director's Interest Notice07/05/12
BNOAppendix 3B03/05/12
BNOAppendix 4C - quarterlyPRICE SENSITIVE30/04/12
BNOJoint Bionomics and Ironwood Roadshow18/04/12
BNOChange of Director's Interest Notice17/04/12
BNOAppendix 3B17/04/12
BNOOpen Briefing - CEO on BNC105 Ovarian Cancer TrialPRICE SENSITIVE03/04/12
BNOBNC105 Ovarian Cancer ProgressPRICE SENSITIVE02/04/12
BNOAppendix 3B27/03/12
BNOBNC105 Ovarian Cancer Trial ApprovedPRICE SENSITIVE23/03/12
BNOAppendix 3B06/03/12
ABC +SandP Indices Announces March Quarterly Rebalance02/03/12
BNOUS and UK Investor Presentation01/03/12
BNOChange of Director's Interest Notice21/02/12
BNOBionomics NOW February 2012 Newsletter21/02/12
BNOCEO Broadcast - BNO Targets Alzheimer's Disease20/02/12
BNOAppendix 3B16/02/12
BNOBionomics Targets Alzheimer's DiseasePRICE SENSITIVE16/02/12
BNOHalf Yearly Report and AccountsPRICE SENSITIVE14/02/12
BNOBNC105 Renal Cancer Trial Data Presented at ASCO-GUPRICE SENSITIVE03/02/12
BNOAppendix 3B31/01/12
BNOAppendix 4C - quarterlyPRICE SENSITIVE31/01/12
BNOAppendix 3B23/01/12
BNOAppendix 3B16/01/12
BNOCEO Biotech Showcase Presentation 201209/01/12
BNOCEO Update and US Investor Presentation09/01/12
BNOAudio Broadcast - CEO Discusses Ironwood Agreement05/01/12
BNOIronwood and Bionomics Announce AgreementPRICE SENSITIVE05/01/12
BNOTrading HaltPRICE SENSITIVE04/01/12
BNOCeasing to be a substantial holder21/12/11
BNOChange in substantial holding20/12/11
BNORights Issue - Letter to Nominees
18/03/13
BNOBionomics CEO Named BioSpectrum Asia Person of the Year 2013
18/03/13
BNORights Issue - Letter to Eligible Shareholders
05/03/13
BNOUnderwritten Rights Issue Offer Booklet
04/03/13PRICE SENSITIVE
BNOCleansing Notice Under Section 708AA of the Corporations Act
04/03/13
BNOAppendix 3B
04/03/13
BNOUnderwritten Rights Issue to Raise $16.4 Million
04/03/13PRICE SENSITIVE
BNOTrading Halt
28/02/13PRICE SENSITIVE
BNOAppendix 3B
15/02/13
BNOHalf Yearly Report and Accounts
14/02/13PRICE SENSITIVE
BNOBNO Provides BNC101 Update at US Cancer Stem Cell Conference
11/02/13PRICE SENSITIVE
BNOBNC375 Alzheimer's Disease Data Presented at Conference
04/02/13PRICE SENSITIVE
BNOBionomics NOW February 2013 Newsletter
01/02/13
BNOAppendix 3B
31/01/13
BNOAppendix 4C - quarterly
31/01/13PRICE SENSITIVE
BNOBionomics R&D Tax Incentive for FY2012
15/01/13PRICE SENSITIVE
BNOCEO Update and US Investor Presentation
09/01/13PRICE SENSITIVE
BNOFinal Director's Interest Notice
03/01/13
BNOBNC210 US TRIAL
21/12/12PRICE SENSITIVE
BNOAppendix 3B
21/12/12
BNOBionomics New Alzheimer's Drug Candidate
14/12/12PRICE SENSITIVE
BNOAppendix 3B
12/12/12
BNOChange of Director's Interest Notice
12/12/12
BNOChange of Director's Interest Notice
12/12/12
BNOChange of Director's Interest Notice
12/12/12
BNOAnnual General Meeting 2012 Results
14/11/12
BNOOutgoing Chairman's Address
14/11/12
BNOCEO & Managing Director AGM Presentation 2012
14/11/12PRICE SENSITIVE
BNOCEO Broadcast - IND Application for Anti-Anxiety Drug
09/11/12
BNOIND Submission to FDA for BNC210 Anti-Anxiety Drug Candidate
08/11/12PRICE SENSITIVE
BNOAppendix 4C - quarterly
31/10/12PRICE SENSITIVE
BNOChange in substantial holding
29/10/12
BNOBionomics ASX Small to Mid Caps Investor Presentation
17/10/12
BNOALPHA 7 PROGRAM TO BE SHOWCASED AT NEUROSCIENCE 2012
16/10/12PRICE SENSITIVE
BNONotice of Annual General Meeting/Proxy Form
12/10/12
BNOBionomics Annual Report 2012
12/10/12
BNORetirement of Chairman
11/10/12
BNOChange of Director's Interest Notice
05/10/12
BNOAppendix 3B
03/10/12
BNOChange of Director's Interest Notice
02/10/12
BNOChange of Director's Interest Notice
26/09/12
BNOAppendix 3B
26/09/12
BNOCleansing Notice Under Section 708A of the Corporations Act
26/09/12
BNOInitial Director's Interest Notice
20/09/12
BNOInitial Director's Interest Notice
20/09/12
BNOChange in substantial holding
18/09/12
BNOBionomics Appoints Graeme Kaufman Non-Executive Director
18/09/12
BNOBNO Acquires US-Based Cancer Stem Cell Company Presentation
17/09/12
BNOBionomics Acquires US-Based Cancer Stem Cell Company
17/09/12PRICE SENSITIVE
BNOBionomics Key Additions to Executive Team
12/09/12
BNOFDA Approval for Ironwood
31/08/12PRICE SENSITIVE
BNOAppendix 3B
21/08/12
BNOBionomics August 2012 Investor Presentation
17/08/12
BNOChange of Director's Interest Notice
15/08/12
BNOFull Year Statutory Accounts
15/08/12
BNOBionomics' 2011/2012 Preliminary Final Results
15/08/12PRICE SENSITIVE
BNOBionomics Secures Key US Patent for VDA BNC105
15/08/12PRICE SENSITIVE
BNOAppendix 3B
02/08/12
BNOAppendix 4C - quarterly
30/07/12PRICE SENSITIVE
BNOBionomics NOW July 2012 Newsletter
06/07/12
BNOOpen Briefing - CEO on Kv1.3 Program and Outlook
27/06/12PRICE SENSITIVE
BNOUS Patent Granted for Kv1.3 Program
26/06/12PRICE SENSITIVE
BNOChange of Director's Interest Notice
19/06/12
BNOAppendix 3B
15/06/12
BNOBionomics to Expand KV1.3 Program
15/06/12PRICE SENSITIVE
BNOCEO Broadcast - BNC105 Trial Data
13/06/12
BNOBNC105 Trial Data Presented at ASCO
01/06/12PRICE SENSITIVE
BNOBionomics Launches BNC105 Ovarian Cancer Trial
24/05/12PRICE SENSITIVE
BNOLife Sciences Conference Investor Presentation
23/05/12
BNOChange of Director's Interest Notice
07/05/12
BNOAppendix 3B
03/05/12
BNOAppendix 4C - quarterly
30/04/12PRICE SENSITIVE
BNOJoint Bionomics and Ironwood Roadshow
18/04/12
BNOChange of Director's Interest Notice
17/04/12
BNOAppendix 3B
17/04/12
BNOOpen Briefing - CEO on BNC105 Ovarian Cancer Trial
03/04/12PRICE SENSITIVE
BNOBNC105 Ovarian Cancer Progress
02/04/12PRICE SENSITIVE
BNOAppendix 3B
27/03/12
BNOBNC105 Ovarian Cancer Trial Approved
23/03/12PRICE SENSITIVE
BNOAppendix 3B
06/03/12
ABC +SandP Indices Announces March Quarterly Rebalance
02/03/12
BNOUS and UK Investor Presentation
01/03/12
BNOChange of Director's Interest Notice
21/02/12
BNOBionomics NOW February 2012 Newsletter
21/02/12
BNOCEO Broadcast - BNO Targets Alzheimer's Disease
20/02/12
BNOAppendix 3B
16/02/12
BNOBionomics Targets Alzheimer's Disease
16/02/12PRICE SENSITIVE
BNOHalf Yearly Report and Accounts
14/02/12PRICE SENSITIVE
BNOBNC105 Renal Cancer Trial Data Presented at ASCO-GU
03/02/12PRICE SENSITIVE
BNOAppendix 3B
31/01/12
BNOAppendix 4C - quarterly
31/01/12PRICE SENSITIVE
BNOAppendix 3B
23/01/12
BNOAppendix 3B
16/01/12
BNOCEO Biotech Showcase Presentation 2012
09/01/12
BNOCEO Update and US Investor Presentation
09/01/12
BNOAudio Broadcast - CEO Discusses Ironwood Agreement
05/01/12
BNOIronwood and Bionomics Announce Agreement
05/01/12PRICE SENSITIVE
BNOTrading Halt
04/01/12PRICE SENSITIVE
BNOCeasing to be a substantial holder
21/12/11
BNOChange in substantial holding
20/12/11
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.